FDA Warning Letter — Acorda Therapeutics, Inc.

Case 232754 — FEI 3002457563

The FDA took a Warning Letter action against Acorda Therapeutics, Inc. on May 10, 2012 (Pearl River, NY). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Acorda Therapeutics, Inc.
Date
May 10, 2012
Fiscal Year
2012
Product Type
Drugs
Center
CDER
Location
Pearl River, NY (United States)